-A A +A

Nauka

Polski

The role of 18F-Fluorodeoxyglucose Positron Emission Tomography in patients with suspected recurrence or metastatic differentiated thyroid carcinoma with elevated serum thyroglobulin and negative I-131 whole body scan

Title: The role of 18F-Fluorodeoxyglucose Positron Emission Tomography in patients with suspected recurrence or metastatic differentiated thyroid carcinoma with elevated serum thyroglobulin and negative I-131 whole body scan
Author(s): Trybek, Tomasz; Kowalska, Aldona; Lesiak, Jacek; et al.
Source: Nuclear medicine review. Central & Eastern Europe Volume: 17 Issue: 2 Pages: 87-93 Published: 2014

Polski

Type 2 Diabetes-Related Variants Influence on the Risk of Developing Multiple Myeloma: Results from the Immense Consortium

Title: Type 2 Diabetes-Related Variants Influence on the Risk of Developing Multiple Myeloma: Results from the Immense Consortium
Author(s): Sainz, Juan; Belen Lupianezs, Carmen; Campa, Daniele; et al.
Source: Blood Volume: 124 Issue: 21 Published: 2014
Times Cited: 0

Polski

X-Ray Fluorescence Techniques in Medical Applications: Reference Values of Elements in Human Serum, Urine and Hair

Title: X-Ray Fluorescence Techniques in Medical Applications: Reference Values of Elements in Human Serum, Urine and Hair
Author(s): Majewska, U.; Banas, D.; Braziewicz, J.; et al.
Source: Acta Physica Polonica A Volume: 125 Issue: 4 Pages: 864-868 Published: 2014
Times Cited: 3

Polski

ACTIVE TRANSPORT OF RB PROTEIN FROM THE NUCLEUS TO THE CYTOPLASM AS ONE OF THE DEVELOPMENT MECHANISMS OF HER2-POSITIVE BREAST CANCER

Title: ACTIVE TRANSPORT OF RB PROTEIN FROM THE NUCLEUS TO THE CYTOPLASM AS ONE OF THE DEVELOPMENT MECHANISMS OF HER2-POSITIVE BREAST CANCER
Author(s): Kowalik, Artur; Kopczynski, Janusz; Wypiorkiewicz, Elzbieta; et al.
Source: Polish Journal of Pathology Volume: 64 Issue: 1 Pages: 9-14 Published: 2013
Times Cited: 2
DOI: 10.5114/pjp.2013.34597

Polski

ADVERSE EVENT PROFILE BY AGE FOR VINTAFOLIDE plus PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) VS PLD ALONE IN PLATINUM-RESISTANT OVARIAN CANCER

Title: ADVERSE EVENT PROFILE BY AGE FOR VINTAFOLIDE plus PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) VS PLD ALONE IN PLATINUM-RESISTANT OVARIAN CANCER
Author(s): Coleman, R.; Bidzinski, M.; Kutarska, E.; et al.
Source: International Journal of Gynecological Cancer Volume: 23 Issue: 8 Published: 2013
Times Cited: 0

Polski

Adverse event profile by folate receptor status for vintafolide plus pegylated liposomal doxorubicin (PLD) vs PLD alone in platinum-resistant ovarian cancer

Title: Adverse event profile by folate receptor status for vintafolide plus pegylated liposomal doxorubicin (PLD) vs PLD alone in platinum-resistant ovarian cancer
Author(s): Herzog, T.; Kutarska, E.; Bidzinski, M.; et al.
Source: European Journal of Cancer Volume: 49 Pages: S731 Published: 2013
Times Cited: 0

Polski

Adverse event profile by therapy cycle for vintafolide plus pegylated liposomal doxorubicin (PLD) versus PLD alone in platinum-resistant ovarian cancer

Title: Adverse event profile by therapy cycle for vintafolide plus pegylated liposomal doxorubicin (PLD) versus PLD alone in platinum-resistant ovarian cancer
Author(s): Symanowski, James Thomas; Kutarska, Elzbieta; Bidzinski, Mariusz; et al.
Source: Journal of Clinical Oncology Volume: 31 Issue: 15 Published: 2013
Times Cited: 0

Polski

Strony

Udostępnij
Subskrybuj RSS - Nauka